Breaking
New Drug Approved by F.D.A. for PancreaticCancer Could Be First of Many
Companies are testing dozens of similar drugs in cancers of the pancreas, lung, colon and more.
Read full story on The New York Times →
Global — Rebecca Robbins and Carolyn Y. Johnson


